Skip to main content
. 2008 Jun 9;29(7):1386–1393. doi: 10.1093/carcin/bgn136

Table II.

GSTM1, GSTP1, GSTT1 and NAT1 genotypes and NAT2 and CYP1A2 phenotypes in relation to risk of bladder cancer among non-Hispanic whites, The Los Angeles Bladder Cancer Study

Genotypes/phenotypes Bladder cancer patientsa Control subjectsa Multivariate-adjusted OR (95% CI)b
GSTM1
    Non-null (0) 275 351 1.00
    Null (1) 387 335 1.58 (1.25–1.99)
GSTT1
    Non-null (0) 518 556 1.00
    Null (1) 140 124 1.24 (0.93–1.66)
GSTP1
    AA 301 284 1.00
    AB 274 327 0.83 (0.64–1.06)
    BB 82 73 1.02 (0.70–1.49)
    AA or AB (0) 575 611 1.00
    BB (1) 82 73 1.12 (0.78–1.61)
Summed GST index
    0 195 262 1.00
    1 324 306 1.52 (1.16–1.97)
    2–3 136 107 1.80 (1.28–2.53)
    P trend 0.002
NAT1
    Non-NAT1*10 434 434 1.00
    NAT1*10 215 243 0.96 (0.75–1.23)
NAT2 phenotypec
    Rapid acetylators 271 291 1.00
    Slow acetylators 364 315 1.11 (0.87–1.41)
CYP1A2 indexc
    Low 314 301 1.00
    High 321 305 1.00 (0.78–1.27)
a

The following subjects with missing information on genotypes or phenotypes were excluded from the relevant analysis: GSTM1 on 4 control subjects, GSTT1 on 4 case patients and 10 control subjects, GSTP1 on 5 case patients and 6 control subjects, summed GST index on 7 case patients and 15 controls, NAT1 on 18 case patients and 22 controls and NAT2 and CYP1A2 on 8 case patients and 3 controls.

b

ORs were derived from unconditional logistic regression models that included the following covariates: age (years), gender, level of education (high school or below, 1–4 years of college, graduate school or above), currently smoking (no, yes), number of cigarettes smoked per day, number of years of smoking, total number of non-steroidal anti-inflammatory drug pills used over lifetime (non-user, <1441 and 1441+), ever use of permanent hair dye (no, yes), ever held a high-risk job (no, yes) and 4-ABP–Hb adducts in tertile (a separate category was created for 65 cases and 53 controls with missing values who were included the multivariate analysis).

c

See the Materials and Methods section for the definitions for the rapid/slow acetylators as well as for the low/high CYP1A2 index.